Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 236-244-1 | CAS number: 13254-34-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Acute Inhalation Toxicity
In line with Column 2, point 8.5.2, Annex VIII of Regulation 1907/2006, an acute inhalation study does not need to be performed as the substance has a low vapour pressure and the use of this substance will not result in aerosols, particles or droplets of an inhalable size, so exposure to humans via the inhalatory route will be unlikely to occur. The acute toxicity endpoint has been addressed by assessing the toxicity via the oral , which is more appropriate when considering the properties of this substance.
Acute Dermal Toxicity
In line with section 1.1, Annex XI of Regulation 1907/2006, an acute dermal toxicity study does not need to be per-formed as use of existing data, from the supporting study, indicates that the substance it likely to have an LD50 above the limits of classification for acute dermal toxicity.
Acute Oral Toxicity
The acute oral toxicity in rats was determined to be 2000 mg/kg using a weight of the evidence approach considering two pre-GLP studies.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- 1976
- Reliability:
- 4 (not assignable)
- Rationale for reliability incl. deficiencies:
- other: Documentation insufficient for assessment: Non-GLP study; no data about purity and no certificate of analysis of the test substance; no details on age, gender, weight and strain of rats and housing conditions
- Principles of method if other than guideline:
- Standard acute method (limit test)
- GLP compliance:
- no
- Remarks:
- pre-GLP
- Test type:
- standard acute method
- Limit test:
- yes
- Specific details on test material used for the study:
- - Name of test material (as cited in study report): Dimetol
- Species:
- rat
- Strain:
- not specified
- Sex:
- not specified
- Details on test animals or test system and environmental conditions:
- None
- Route of administration:
- oral: unspecified
- Vehicle:
- not specified
- Details on oral exposure:
- None
- Doses:
- 5000 mg/kg bw
- No. of animals per sex per dose:
- Total no. of animals = 10
- Control animals:
- no
- Details on study design:
- - Animals were observed for mortality and clinical signs of toxicity for 14 days.
- Necropsy performed: Yes - Statistics:
- None
- Preliminary study:
- Not applicable
- Key result
- Sex:
- not specified
- Dose descriptor:
- LD50
- Effect level:
- > 5 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- - 2/10 animals died on Day 1.
- Clinical signs:
- other: - At 2 h, lethargy, ataxia and loss of righting reflex were noted in animals. - At 24 h, lethargy in 3/8 animals and piloerection in 2/8 animals were noted.
- Gross pathology:
- At necropsy, lungs and stomach were red in 2 animals.
- Other findings:
- None
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The oral LD50 for Dimetol is higher than 5000 mg/kg bw in rats therefore it is not classified according to the Directive 67/548/EEC and the CLP Regulation.
- Executive summary:
In an acute oral toxicity study, 10 rats were given a single oral dose of Dimetol at 5000 mg/kg bw. Animals were then observed for mortality and clinical signs of toxicity for 14 days.
Two of the 10 rats died on Day 1. At 2 h, lethargy, ataxia and loss of righting reflex were noted in rats. At 24 h, lethargy in 3/8 rats and piloerection in 2/8 rats were noted. At necropsy, lungs and stomach were red in 2 rats.
The oral LD50 for Dimetol is higher than 5000 mg/kg bw in rats therefore it is not classified according to the Directive 67/548/EEC and the CLP Regulation.
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- 1969
- Reliability:
- 4 (not assignable)
- Rationale for reliability incl. deficiencies:
- documentation insufficient for assessment
- Remarks:
- Non-GLP study; no data about purity and no certificate of analysis of the test substance; effects on clinical signs, body weights and gross pathology were not reported; observation period: 5 days; no. of animals at highest dose level < 5; no details on the environmental conditions
- Reason / purpose for cross-reference:
- reference to other study
- Principles of method if other than guideline:
- Method: Groups of rats (2 or 5/sex/dose) were given a single oral dose of the test item at 4.0, 5.0, 5.5, 6.0 and 7.0 mL/kg bw in corn oil and then observed for mortality for 5 days.
- GLP compliance:
- no
- Remarks:
- pre-GLP
- Test type:
- standard acute method
- Limit test:
- no
- Specific details on test material used for the study:
- - Name of test material (as cited in study report): DIMETOL
- Date received: 26 May 1969
- Physical state: Clear colourless liquid - Species:
- rat
- Strain:
- other: CFE rats of Carworth strain
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Weight at study initiation: 125-150 g
- Housing: Animals were housed in raised wire mesh cages.
- Fasting period before study: 18 h
- Diet: Lab Blox diet, ad libitum
- Water: Ad libitum - Route of administration:
- oral: gavage
- Vehicle:
- corn oil
- Details on oral exposure:
- DOSAGE PREPARATION: Test material was diluted one part to five parts with corn oil (v/v) prior to dosing.
- Doses:
- 4.0, 5.0, 5.5, 6.0 and 7.0 mL/kg bw
- No. of animals per sex per dose:
- 7 mL/kg bw: 2/sex/dose
4.0, 5.0, 5.5 and 6 mL/kg bw: 5/sex/dose - Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 5 days
- Statistics:
- LD50 value was calculated using the method of Litchfield and Wilcoxon (1949).
- Preliminary study:
- Not applicable
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 5.82 mL/kg bw
- Based on:
- test mat.
- 95% CL:
- 5.35 - 6.32
- Remarks on result:
- other: equivalent to 4714 (4333-5119) mg/kg bw; calculated using the density of 0.81 g/L (literature)
- Mortality:
- - Mortalities were 0/10, 2/10, 3/10, 6/10 and 4/4 at 4.0, 5.0, 5.5, 6.0 and 7.0 mL/kg bw, respectively.
- Clinical signs:
- other: No data
- Gross pathology:
- No data
- Other findings:
- None
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The oral LD50 of DIMETOL is higher than 2000 mg/kg bw in rats therefore it is not classified according to the Directive 67/548/EEC and the CLP Regulation.
- Executive summary:
In an acute oral toxicity study, groups of CFE rats (2 or 5/sex/dose) were given a single oral dose of DIMETOL at 4.0, 5.0, 5.5, 6.0 and 7.0 mL/kg bw in corn oil. Animals were then observed for mortality for 5 days and LD50 value was calculated using Litchfield and Wilcoxon method (1949).
After 5 days, mortalities were 0/10, 2/10, 3/10, 6/10 and 4/4 at 4.0, 5.0, 5.5, 6.0 and 7.0 mL/kg bw, respectively. In this study, the combined oral LD50 of DIMETOL in rats was considered to be 5.82 (5.35-6.32) mL/kg bw [equivalent to 4714 (4333-5119) mg/kg bw; calculated using the density of 0.81 g/L (literature)]
The oral LD50 of DIMETOL is higher than 2000 mg/kg bw in rats therefore it is not classified according to the Directive 67/548/EEC and the CLP Regulation.
Referenceopen allclose all
None
None
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
Acute toxicity: via inhalation route
Link to relevant study records
- Endpoint:
- acute toxicity: inhalation
- Data waiving:
- study scientifically not necessary / other information available
- Justification for data waiving:
- other:
- Reason / purpose for cross-reference:
- data waiving: supporting information
- Reason / purpose for cross-reference:
- data waiving: supporting information
Reference
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Reliability:
- 4 (not assignable)
- Rationale for reliability incl. deficiencies:
- other: Documentation insufficient for assessment: Non-GLP study; no data about purity and no certificate of analysis of the test substance; no details on age, gender, weight and strain of rats and housing conditions
- Principles of method if other than guideline:
- Standard acute method (limit test)
- GLP compliance:
- no
- Remarks:
- pre-GLP
- Test type:
- standard acute method
- Limit test:
- yes
- Specific details on test material used for the study:
- - Name of test material (as cited in study report): Dimetol
- Species:
- rabbit
- Strain:
- not specified
- Sex:
- not specified
- Type of coverage:
- not specified
- Vehicle:
- not specified
- Doses:
- 5000 mg/kg bw
- No. of animals per sex per dose:
- Total no. of animals = 10
- Control animals:
- no
- Details on study design:
- - Animals were observed for mortality and clinical signs of toxicity for 14 days.
- Necropsy performed: Yes - Sex:
- not specified
- Dose descriptor:
- LD50
- Effect level:
- > 5 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No animals died
- Clinical signs:
- other: Skin irritation observed during acute dermal toxicity study: slight redness - 2/10 moderate redness - 8/10 sllight edema - 1/10 moderate edema - 9/10
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The dermal LD50 for Dimetol is higher than 5000 mg/kg bw in rabbits therefore it is not classified according to the Directive 67/548/EEC and the CLP Regulation.
- Endpoint:
- acute toxicity: dermal
- Data waiving:
- study scientifically not necessary / other information available
- Justification for data waiving:
- other:
Referenceopen allclose all
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Justification for classification or non-classification
- low vapour pressure and
- use of this substance will not result in aerosols, particles or droplets of an inhalable size, so exposure to humans via the inhalatory route will be unlikely to occur.
A weight of the evidence approach was used in the classification of acute oral toxicity. Two pre-GLP studies, conducted in rats, were evaluated. The first, in 1976 by Moreno, was a limit study in which 10 animals were dosed with 5000 mg/kg/bw Dimetol and observed for 14 days. No deaths occurred during the observation period. Thus, the resulting LD50 was >5000 mg/kg/bw. The second study, Wolven in 1969, used dose levels of 4.0, 5.0, 5.5, 6.0 and 7.0 mL/kg bw with mortality noted as follows: 0/10, 2/10, 3/10, 6/10 and 4/4 at 4.0, 5.0, 5.5, 6.0 and 7.0 mL/kg bw, respectively.
In this study, the oral LD50 of DIMETOL in rats was considered to be 5.82 (5.35-6.32) mL/kg bw [equivalent to 4714 (4333-5119) mg/kg bw; calculated using the density of 0.81 g/L (literature)]
The acute oral toxicity in rats was determined to be >2000 mg/kg bw using a weight of the evidence approach considering two pre-GLP studies. Therefore, classification according to DSD or GHS is not justified.
Classification for acute inhalation toxicity is not justified due to the data waiver of this endpoint which was based on DIMETOL's
Classification for acute dermal toxicity is not justified due to the data waiver of this endpoint as use of existing data, from the supporting study, indicates that the substance it likely to have an LD50 above the limits of classification for acute dermal toxicity.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.